Bayesian data augmentation methods for the synthesis of qualitative and quantitative research findings

Quality and Quantity

Volumn 45, Issue 3, 2011, Pages 653-669

  Crandell, Jamie L ^a,b   Voils, Corrine I ^c   Chang, YunKyung ^b   Sandelowski, Margarete ^b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Bayesian data augmentation; Cross design synthesis; Gibbs sampling; Meta analysis; Meta synthesis; Missing data; Synthesis

Indexed keywords

EID: 79952244514     PISSN: 00335177     EISSN: 15737845     Source Type: Journal    
DOI: 10.1007/s11135-010-9375-z     Document Type: Article

References (49)

1. *Abel, E., Painter, L.: Factors that influence adherence to HIV medications: Perceptions of women and health care providers. J. Assoc. Nurses AIDS Care 14, 61-69 (2003).
2. Albert J. H., Chib S.: Bayesian analysis of binary and polychotomous response data. J. Am. Stat. Assoc. 88, 669-679 (1993).
3. Barbour R. S., Barbour M.: Evaluating and synthesizing qualitative research: the need to develop a distinctive approach. J. Eval. Clin. Pract. 9, 179-186 (2003).
4. Berry D. A.: Bayesian clinical trials. Nat. Rev. Drug Discov. 5, 27-36 (2006).
5. Casella G., George E. I.: Explaining the Gibbs sampler. Am. Stat. 46, 167-174 (1992).
6. Chang Y., Voils C. I., Sandelowski M., Hasselblad V., Crandell J. L.: Transforming verbal counts in reports of qualitative descriptive studies into numbers. West. J. Nurs. Res. 31, 837-852 (2009).
7. Choi H., Shen R., Chinnaiyan A. M., Ghosh D.: A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. BMC Bioinformatics 8, 364 (2007).
8. Dixon-Woods M., Agarwal S., Jones D., Young B., Sutton A.: Synthesizing qualitative and quantitative evidence: a review of possible methods. J. Health Serv. Res. Policy 10, 45-53 (2005).
9. *Douglass, J. L., Sowell, R. L., Phillips, K. D.: Using Peplau's theory to examine the psychosocial factors associated with HIV-infected women's difficulty in taking their medications. J. Theory Constr. Test. 7, 10-17 (2003).
10. *Durante, A. J., Bova, C. A., Fennie, K. P., Danvers, K. A., Holness, D. R., Burgess, J. D., et al.: Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results. AIDS Care. 15, 103-115 (2003).
11. Eakin J. M., Mykhalovskiy E.: Reframing the evaluation of qualitative health research: reflections on a review of appraisal guidelines in the health sciences. J. Eval. Clin. Pract. 9, 187-194 (2003).
12. *Edwards, L. V.: Perceived social support and HIV/AIDS medication adherence among AfricanAmerican women. Qual. Health Res. 16, 679-691 (2006).
13. *Gant, L. M., Welch, L. A.: Voices less heard: HIV-positive African American women, medication adherence, sexual abuse, and self-care. J. HIV/AIDS Soc. Serv. 3, 67-91 (2004).
14. Gelman A., Carlin J. B., Stern H. S, Rubin D. B.: Bayesian Data Analysis (2nd edn). Chapman and Hall/CRC, Boca Raton, Florida (2004).
15. Gerring J.: Case study research: Principles and practices. Cambridge University Press, New York (2007).
16. Goldsmith M. R., Bankhead C. R., Austoker J.: Synthesizing quantitative and qualitative research in evidence-based patient information. J. Epidemiol. Community Health 61, 262-270 (2007).
17. Hammersley, M.: Systematic or unsystematic, is that the question? Some reflections on the science, art, and politics of reviewing research evidence. Paper presented to Public Health Evidence Steering Group of the Health Development Agency. Available via: National Institute for Clinical Excellence. http://www. nice. org. uk/niceMedia/pdf/sys_unsys_phesg_hammersley. pdf. Cited 2 February, 2009 (2002).
18. Harden A., Thomas J.: Methodological issues in combining diverse study types in systematic reviews. Int. J. Soc. Res. Methodol. 8, 257-271 (2005).
19. Horrace W. C.: Some results on the multivariate truncated normal distribution. J. Multivar. Anal. 94, 209-221 (2005).
20. *Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., et al.: A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16, 2175-2182 (2002).
21. *Ickovics, J. R., Wilson, T. E., Royce, R. A., Minkoff, H. L., Fernandez, M. I., Fox-Tierney, R., et al.: Prenatal and postpartum zidovudine adherence among pregnant women with HIV results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. JAIDS: JAIDS 30, 311-315 (2002).
22. Jones, D. R., Dixon-Woods, M., Abrams, K., Fitzpatrick, R.: Meta-analysis of qualitative and quantitative evidence: full report of research activities and results (ESRC ALCD 2 programme). Available by searching the ESRC social sciences repository. http://www. esrcsocietytoday. ac. uk. Cited 6 January, 2009. (2005).
23. *Kalichman, S. C., Rompa, D., DiFonzo, K., Simpson, D., Austin, J., Luke, W., et al.: HIV treatment adherence in women living with HIV/AIDS: Research based on the Information-Motivation-Behavioral Skills Model of Health Behavior. J. Assoc. Nurses AIDS Care. 12, 58-67 (2001).
24. Little R. J. A., Rubin D. B.: Statistical Analysis with Missing Data (2nd ed). Wiley, Hoboken, NJ (2002).
25. *Liu, H., Longshore, D., Williams, J. K., Rivkin, I., Loeb, T., Warda, U. S., et al.: Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse. AIDS Behav. 10, 279-286 (2006).
26. Mills E. J., Wilson K., Rachlis B., Griffith L., Wu P., Guyatt G., Cooper C.: Barriers to participation in HIV drug trials: a systematic review. Lancet Infect. Dis. 6, 32-38 (2006a).
27. Mills E. J., Seely D., Rachlis B., Griffith L., Wu P., Wilson K., Ellis P., Wright J.: Barriers to participation of clinical trials in cancer: a meta-analysis and systematic review of patent-reported factors. Lancet Oncol. 7, 141-148 (2006b).
28. *Misener, T. R., Sowell, R. L.: HIV infected women's decisions to take antiretrovirals. West. J. Nurs. Res. 20, 431-447 (1998).
29. *Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L.: Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. JAIDS: JAIDS 18, 341-348 (1998).
30. *Murphy, D. A., Greenwell, L., Hoffman, D.: Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health 36, 97-111 (2002).
31. *Phillips, K. D., Moneyham, L., Murdaugh, C., Boyd, M. R., Tavakoli, A., Jackson, K., et al.: Sleep disturbance and depression as barriers to adherence. Clin. Nurs. Res. 14, 273-293 (2005).
32. Pope C., Mays N., Popay J.: Synthesizing qualitative and quantitative health evidence. Open University Press, Berkshire, England (2007).
33. *Powell-Cope, G. M., White J., Henkelman, E. J., Turner, B. J.: Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care. 15, 239-249 (2003).
34. *Richter, D. L., Sowell, R. L., Pluto, D. M.: Attitudes toward antiretroviral therapy among African American women. Am. J. Health Behav. 26, 25-33 (2002).
35. *Roberts, K. J., Mann, T.: Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 12, 377-386 (2000).
36. Roberts K., Dixon-Woods M., Fitzpatrick R., Abrams K., Jones D. R.: Factors affecting uptake of childhood immunisation: an example of Bayesian synthesis of qualitative and quantitative evidence. Lancet 360, 1596-1599 (2002).
37. Sandelowski M., Voils C. I., Barroso J.: Comparability work and the management of difference in research synthesis studies. Soc. Sci. Med. 64, 236-247 (2007).
38. *Sankar, A., Luborsky, M., Schuman, P., Roberts, G.: Adherence discourse among African-American women taking HAART. AIDS Care 14, 203-218 (2002).
39. *Schrimshaw, E. W., Siegel, K., Lekas, H.-M.: Changes in attitudes toward antiviral medication: a comparison of women living with HIV/AIDS in the pre-HAART and HAART eras. AIDS Behav. 9, 267-279 (2005).
40. *Siegel, K., Gorey, E.: HIV-infected women: barriers to AZT use. Soc. Sci. Med. 45, 15-22 (1997).
41. *Siegel, K., Lekas, H.-M., Schrimshaw, E. W., Johnson, J. K.: Factors associated with HIV-infected women's use or intention to use AZT during pregnancy. AIDS Educ. Prev. 13, 189-206 (2001).
42. *Sowell, R. L., Phillips, K. D., Seals, B. F., Misener, T. R., Rush, C.: HIV-infected women's experiences and beliefs related to AZT therapy during pregnancy. AIDS Patient Care STDs 15, 201-209 (2001).
43. *Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., et al.: Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the HER Study. JAIDS: JAIDS 28, 124-131 (2001).
44. Sutton A. J., Higgins J. P. T.: Recent developments in meta-analysis. Stat. Med. 27, 625-650 (2007).
45. Voils C. I., Sandelowski M., Barroso J., Hasselblad V.: Making sense of qualitative and quantitative findings in mixed research synthesis studies. Field Methods 20, 3-25 (2008).
46. Voils C. I., Hasselblad V., Crandell J. L., Chang Y., Lee E., Sandelowski M.: A Bayesian method for the synthesis of evidence from qualitative and quantitative reports: an example from the literature on antiretroviral medication adherence. J. Health Serv. Res. Policy 14, 226-233 (2009).
47. *Wilson, T. E., Barrón, Y., Cohen, M., Richardson, J., Greenblatt, R., Sacks, H. S., et al.: Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin. Infect. Dis. 34, 529-534 (2002).
48. *Wilson, T. E., Ickovics, J. R., Fernandez, M. I., Koenig, L. J., Walter, E.: Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. Am. J. Obstet. Gynecol. 184, 1235-1240 (2001).
49. *Wood, S. A., Tobias, C., McCree, J.: Medication adherence for HIV-positive women caring for children: in their own words. AIDS Care 16, 909-913 (2004).